Intrinsic value of ProFunds Biotechnology UltraSector Fund Service Class (BIPSX)

Live fair value data for ProFunds Biotechnology UltraSector Fund Service Class (BIPSX) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +13.0%

Margin of Safety: +11.5%

Current Price: $70.00

Valuation: Undervalued

Confidence: 5.0/10

Visual Bar

Market Price $70.00Intrinsic Value Locked

Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Is ProFunds Biotechnology UltraSector Fund Service Class (BIPSX) undervalued or overvalued?

Based on the current model output, ProFunds Biotechnology UltraSector Fund Service Class appears to be undervalued with a upside of 13.00%.

Fair value vs market price — ProFunds Biotechnology UltraSector Fund Service Class (BIPSX)

Unlock premium access to view the live fair value comparison against current market price for BIPSX.

Unlock Fair Value

Frequently Asked Questions - BIPSX

How is BIPSX intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BIPSX.

Is BIPSX undervalued or overvalued right now?

BIPSX is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for BIPSX: open their intrinsic value pages.

Explore Other Stocks

AAPL TSLA NVDA MSFT